NCT06161415View on ClinicalTrials.gov

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
InflammationUveitis
Interventions
DRUG

Laquinimod eye drops

n Laquinimod eye drops 10 mg/ml Dose: Dosing frequency will depend on the groups assigned

Trial Locations (1)

94303

RECRUITING

Spencer Center for Vision Research at the Byers Eye Institute, Palo Alto

All Listed Sponsors
collaborator

Global Ophthalmic Research Center (GORC)

UNKNOWN

lead

Quan Dong Nguyen

OTHER